Octagon Capital Advisors LP 13D and 13G filings for Dianthus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-10-11 4:02 pm Purchase | 2024-09-30 | 13G | Dianthus Therapeutics, Inc. DNTH | Octagon Capital Advisors LP | 1,746,667 6.000% | 1,746,667 (New Position) | Filing |